SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sherman Steven – ‘4’ for 8/21/22 re: Ekso Bionics Holdings, Inc.

On:  Tuesday, 8/23/22, at 3:09pm ET   ·   For:  8/21/22   ·   As:  Director and Officer   ·   Accession #:  1549084-22-53   ·   File #:  1-37854

Previous ‘4’:  ‘4’ on 7/25/22 for 7/21/22   ·   Next:  ‘4’ on 9/26/22 for 9/21/22   ·   Latest:  ‘4/A’ on 6/27/23 for 6/8/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/23/22  Sherman Steven                    4          Dir.,Off.   1:7K   Ekso Bionics Holdings, Inc.       Ekso Bionics Holdin… Inc

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      8K 
                Securities by an Insider --                                      
                wf-form4_166128175210388.xml/3.6                                 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider — wf-form4_166128175210388.xml/3.6
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  8/21/22
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  1549084
Issuer Name:  EKSO BIONICS HOLDINGS, INC.
Issuer Trading Symbol:  EKSO
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1201619
Owner Name:  SHERMAN STEVEN
Reporting Owner Address:
Owner Street 1:  C/O EKSO BIONICS HOLDINGS, INC.
Owner Street 2:  1414 HARBOUR WAY S, STE. 1201
Owner City:  RICHMOND
Owner State:  CA
Owner ZIP Code:  94804
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  Yes
Is Ten Percent Owner?  No
Is Other?  No
Officer Title:  CEO & Chairman
Other Text:
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  8/21/22
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  15,599
Transaction Price Per Share:
Value:  0
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  684,567
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  8/22/22
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  S
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  5,572
Footnote ID:  F1
Transaction Price Per Share:
Value:  2.2036
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  678,995
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Restricted Stock Units
Conversion or Exercise Price:
Footnote ID:  F3
Transaction Date:
Value:  8/21/22
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  15,599
Transaction Price Per Share:
Value:  0
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F4
Expiration Date:
Footnote ID:  F4
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  15,599.0
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  77,997
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1Represents shares sold by the Reporting Person on August 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the seventh installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022
Footnote - F2The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.24 to $2.20, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.
Footnote - F3The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
Footnote - F4The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The seventh installment of RSUs vested on August 21, 2022 and were delivered to the Reporting Person upon settlement.
Remarks:
Owner Signature:
Signature Name:  /s/ Jerome Wong, as Attorney-in-Fact
Signature Date:  8/23/22


Top
Filing Submission 0001549084-22-000053   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 7:39:42.2pm ET